from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1852/ureG

LFCtreatmentdescriptionclass of inhibitor

-0.131

Amikacinug/mL Amikacintranslation

-0.596

Cap5-10ug/mL Capreomycintranslation

-0.846

Rox10-50 ug/mL Roxithromycintranslation

-0.581

SM2-5 ug/mL Streptomycintranslation

0.521

Tet5-10 ug/mL Tetracyclinetranslation

1.577

Rif0.2-5ug/mL Rifampicintranscription

0.485

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.201

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.813

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.482

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.919

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.510

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.196

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.530

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.060

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.818

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.534

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.001

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.831

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.165

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.116

KCN5-20 ug/mL Potassium cyaniderespiration

0.367

NaN30.2-2 mM Sodium aziderespiration

-0.422

Nigericin50 uM Nigericinrespiration

0.257

TRC10-150 ug/mL Triclosanrespiration

-0.224

TRZ10-25 ug/mL Thioridazinerespiration

0.094

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.241

menadione6-10 ug/mL Menadionerespiration

0.043

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.228

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.286

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.813

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.786

NRP_1Non-replicating persistence stage 1dosRassociated

0.200

Amp0.2mg/mL AmpicillincellWall

-0.188

Cephalexin20-100 ug/mL CephalexincellWall

-0.665

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.738

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.121

EMB10-20 ug/mL EthambutolcellWall

0.153

Eta12-40 ug/mL EthionamidecellWall

0.218

INH0.2-0.4 ug/mL IsoniazidcellWall

0.005

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.372

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.822

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.014

BZA0.12 mg/mL BenzamidearomaticAmides

0.656

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.558

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.355

H2O24 mM hydrogen peroxideDNAdamaging

0.322

Levo10 ug/mL LevofloxacinDNAdamaging

0.733

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.652

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.189

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.494

UVUV-irradiationDNAdamaging

0.130

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.279

Antimycin12.5-50 ug/mL Antimycin A?

-0.721

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.339

PA_110-50 ug/mL Antitubercular compound PA-1?

0.342

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.305

PA8240.2-2 ug/mL PA-824?

-0.775

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.041

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.803

Verapamil50 uM Verapamil?

-0.443

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.288

methoxatin10-20 ug/mL Methoxatin?